Abstract
The in vitro insulin unfolding had been studied using the “equilibrium unfolding” method where protein is unfolded by reducing reagents in the presence of trace amounts of oxidants such as oxidized glutathione. Nine intermediates were captured in the unfolding process, named as P1A, P2A, P3A, P4A, P3B, P4B, P5B, P6B, and P7B, which were all either A chain derivatives or B chain derivatives. No intermediate with inter-A-B chain disulfide was captured. Based on the character of the intermediates, their distribution during the unfolding process and the hypothetic “transient” intermediates, an in vitro putative unfolding pathway of insulin had been proposed. Besides, the comparison of the intermediates captured in unfolding with the intermediates captured in the refolding process of insulin revealed that both unfolding/ refolding processes of insulin shared common intermediates. Based on these observations we suggested that the unfolding pathway of insulin was similar to the refolding pathway but flowed in the opposite direction.
Keywords: Disulfide, folding, insulin, unfolding, unfolding intermediate, unfolding pathway
Protein & Peptide Letters
Title: In Vitro Unfolding of Insulin: Characterization of Intermediates and Putative Unfolding Pathway
Volume: 17 Issue: 7
Author(s): Jie Zhao, Qi-Long Huang, Yue-Hua Tang, Fu-Kun Zhao and You-Min Feng
Affiliation:
Keywords: Disulfide, folding, insulin, unfolding, unfolding intermediate, unfolding pathway
Abstract: The in vitro insulin unfolding had been studied using the “equilibrium unfolding” method where protein is unfolded by reducing reagents in the presence of trace amounts of oxidants such as oxidized glutathione. Nine intermediates were captured in the unfolding process, named as P1A, P2A, P3A, P4A, P3B, P4B, P5B, P6B, and P7B, which were all either A chain derivatives or B chain derivatives. No intermediate with inter-A-B chain disulfide was captured. Based on the character of the intermediates, their distribution during the unfolding process and the hypothetic “transient” intermediates, an in vitro putative unfolding pathway of insulin had been proposed. Besides, the comparison of the intermediates captured in unfolding with the intermediates captured in the refolding process of insulin revealed that both unfolding/ refolding processes of insulin shared common intermediates. Based on these observations we suggested that the unfolding pathway of insulin was similar to the refolding pathway but flowed in the opposite direction.
Export Options
About this article
Cite this article as:
Zhao Jie, Huang Qi-Long, Tang Yue-Hua, Zhao Fu-Kun and Feng You-Min, In Vitro Unfolding of Insulin: Characterization of Intermediates and Putative Unfolding Pathway, Protein & Peptide Letters 2010; 17 (7) . https://dx.doi.org/10.2174/092986610791306724
DOI https://dx.doi.org/10.2174/092986610791306724 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biomarkers of Diabetic Nephropathy, the Present and the Future
Current Diabetes Reviews Effect of Polyphenolic Compounds from Solanum torvum on Plasma Lipid Peroxidation, Superoxide anion and Cytochrome P450 2E1 in Human Liver Microsomes
Medicinal Chemistry Medical Management of the Diabetic Patient with Coronary Artery Disease
Current Pharmaceutical Design Applications and Limitations of Genetically Modified Mouse Models in Drug Discovery and Development
Current Drug Metabolism Hormones and the Autonomic Nervous System are Involved in Suprachiasmatic Nucleus Modulation of Glucose Homeostasis
Current Diabetes Reviews Endothelial Nitric Oxide Synthase – A Target for Stroke Protection by Statins
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Secreted Aspartic Proteinases as a New Target in the Therapy of Candidiasis
Current Drug Targets Phytosterols: Perspectives in Human Nutrition and Clinical Therapy
Current Medicinal Chemistry Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine
Endocrine, Metabolic & Immune Disorders - Drug Targets New Insights in Prolactin Releasing Peptide (Prrp) in the Brain
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Valproic Acid Metabolism and its Consequences on Sexual Functions
Current Drug Metabolism Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality
Current Drug Targets Targeting Tumor-Associated Antigens to the MHC Class I Presentation Pathway
Endocrine, Metabolic & Immune Disorders - Drug Targets Signaling in “Obesity Neurons”
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents MicroRNA Expression Analysis of Adult-Onset Drosophila Alzheimer`s Disease Model
Current Alzheimer Research Recent Advances in Ethnopharmacological and Toxicological Properties of Bioactive Compounds from <i>Aloe barbadensis</i> (Miller), <i>Aloe vera</i>
Current Bioactive Compounds Estrogen Receptor Alpha: Impact of Ligands on Intracellular Shuttling and Turnover Rate in Breast Cancer Cells
Current Cancer Drug Targets Role of the 5-HT2C Receptor in Atypical Antipsychotics: Hero or Villain?
Current Medicinal Chemistry - Central Nervous System Agents Endogenous Cardioprotective Agents: Role in Pre and Postconditioning
Current Drug Targets Ferritin and Percent Transferrin Saturation Levels Predict Type 2 Diabetes Risk and Cardiovascular Disease Outcomes
Current Diabetes Reviews